Get startedLog in
    Picture of Disruptive Pharma AB (publ) logo

    DPHA — Disruptive Pharma AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: A1M Pharma Drug Candidate Shows Protective Effect Against Acute Kidney Injury In Preclinical Study

    Picture of Disruptive Pharma AB (publ) logoDisruptive Pharma AB (publ)
    10/08/2018 14:03
    Aug 10 (Reuters) - A1M Pharma AB  A1M.ST :
    * A1M PHARMA'S CANDIDATE DRUG ROSGARD SHOWS PROTECTIVE EFFECT AGAINST ACUTE KIDNEY INJURY IN
AMERICAN PRECLINICAL STUDY
    * PHASE I STUDY IS SCHEDULED TO START LATER IN 2018

Source text for Eikon:  ID:nBQNbvPfDw 
Further company coverage:  A1M.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Disruptive Pharma AB (publ)

    See all news